Page last updated: 2024-08-21

benzoxazoles and Retinoblastoma

benzoxazoles has been researched along with Retinoblastoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Fu, Y; Hu, T; Li, K; Li, Z; Song, J; Tang, L	1

Other Studies

1 other study(ies) available for benzoxazoles and Retinoblastoma

Article	Year
mTOR inhibition by TAK-228 is effective against growth, survival and angiogenesis in preclinical retinoblastoma models. Pharmacology research & perspectives, 2022, Volume: 10, Issue:1 Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Benzoxazoles; Cell Line, Tumor; Humans; Inhibitory Concentration 50; Male; Mice; Mice, Inbred NOD; Mice, SCID; Neovascularization, Pathologic; Pyrimidines; Retinal Neoplasms; Retinoblastoma; Signal Transduction; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays	2022

Article

Year

mTOR inhibition by TAK-228 is effective against growth, survival and angiogenesis in preclinical retinoblastoma models.

Pharmacology research & perspectives, 2022, Volume: 10, Issue:1

Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Benzoxazoles; Cell Line, Tumor; Humans; Inhibitory Concentration 50; Male; Mice; Mice, Inbred NOD; Mice, SCID; Neovascularization, Pathologic; Pyrimidines; Retinal Neoplasms; Retinoblastoma; Signal Transduction; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays

2022